Skip to content

Serratus Anterior Plane Block and Costotransverse Block for Analgesia Following Modified Radical Mastectomy Surgeries

Ultrasound Guided Serratus Anterior Plane Block Versus Costotransverse Block on Postoperative Analgesia and Safety Following Modified Radical Mastectomy Surgeries

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06260397
Enrollment
90
Registered
2024-02-15
Start date
2023-12-28
Completion date
2025-03-30
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional Anesthesia Morbidity

Brief summary

Adequate pain management following modified radical mastectomy (MRM) is crucial for early ambulation and patient satisfaction. Breast cancer is the most common malignancy in females, with an increasing incidence in recent years. Surgery is one of the mainstays of therapy for breast cancer, and modified radical mastectomy (MRM) is the most effective and common type of invasive surgical treatment. Post-mastectomy pain syndrome (PMPS) is a surgical complication of breast surgery characterized by chronic neuropathic pain. The aim of this study is to investigate the efficacy and safety of single injection CTB versus SAPB on post-operative acute pain as a part of a multimodal analgesia plan in patients undergoing MRM.

Detailed description

Patients will be divided randomly by the computer into three groups, group (A): will receive serratus anterior plane block, group (B): will receive costotransverse block and group(C): patient controlled analgesia group (PCA). Group (A) (SAPB): SAPB will be performed using an ultrasound machine with a high-frequency linear probe . All patients will be in lateral position to perform the block. At the level of the fourth rib with 45-degree angle, targeting the plane between the latissimus dorsi and serratus muscles, SAPB block will be performed unilaterally on the ipsilateral side of surgery. Group (B) (CTB): CTB will be performed using an ultrasound machine with a high-frequency linear probe. All patients will be in lateral position to perform the block. CTB block will be performed unilaterally on the ipsilateral side of surgery at the level of fourth rib. Group (C) (patient controlled analgesia): After successful extubation, patients will be transferred to PACU. Patients will receive a bolus dose of 5 mg nalbuphine then PCA pump in the form of 20 mg nalbuphine HCL in 100 ml 0.9% normal saline with basal rate of infusion 5ml/hr with self-administration bolus of 0.5ml with 15 min lock-out time.

Interventions

PROCEDUREserratus anterior plane block

using ultrasound, 30 ml of bupivacaine 0.25% will be injected in the plane between the latissimus dorsi and serratus muscles

using ultrasound, 30 ml of bupivacaine 0.25% will be injected in the costotransverse plane of fourth rib

PROCEDUREpatient controlled analgesia

PCA pump in the form of 20 mg nalbuphine HCL in 100 ml 0.9% normal saline with basal rate of infusion 5ml/hr. with self-administration bolus of 0.5ml with 15 min lock-out time.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. American Society of Anaesthesiologists (ASA) Physical Status Class I, II. 2. Scheduled for modified radical mastectomy (MRM). 3. Body weight ranging from 60 to 100 kilograms.

Exclusion criteria

1. Declining to give a written informed consent. 2. History of allergy to the medications used in the study. 3. Contraindications to regional anesthesia (including patient: refusal, coagulopathy, and local infection). 4. Psychiatric disorders. 5. Significant cognitive dysfunction. 6. American Society of Anesthesiologists (ASA) Physical Status Class III and IV. 7. Daily use of opioids. 8. Obesity (BMI \> 35 kg/m2).

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale score at 0,6,12 and 24 hour post-operatively. visual analogue scale is a scale from 0 to 10, 0 represent no pain at all and 10 represent the worst pain24 hour post-operativeVisual Analogue Scale score will be assessed at both rest and arm elevation

Secondary

MeasureTime frameDescription
The total dose of nalbuphine consumption is used postoperatively per patient rescue analgesia for 24.24 hour post-operativedose of nalbuphine consumed by patients
Incidence of chronic pain after 6 months of surgery6 months after surgeryHow many people develop chronic pain after surgery

Countries

Egypt

Contacts

Primary ContactAbdalla Ma Abdalla, master
abdalla.magdy@med.asu.edu.eg00201006717445

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026